Renaissance Technologies's EHC Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 68,200 shares of Encompass Health Corporation (EHC) worth $7.24 M, representing 0.01% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in EHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 660,400 shares. Largest reduction occurred in Q2 2019, reducing 1.13 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Encompass Health Corporation (EHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Encompass Health Corporation (EHC) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -2,800 | Reduce 3.94% | 68,200 | $106.14 |
| Q3 2025 | +18,600 | Add 35.50% | 71,000 | $127.02 |
| Q2 2025 | +1,500 | Add 2.95% | 52,400 | $122.63 |
| Q4 2024 | +19,700 | Add 63.14% | 50,900 | $92.35 |
| Q3 2024 | +31,200 | New Buy | 31,200 | $96.64 |
| Q1 2023 | -4,100 | Sold Out | 0 | $0.00 |
| Q4 2022 | -316,800 | Reduce 98.72% | 4,100 | $0.06 |
| Q3 2022 | +259,800 | Add 425.20% | 320,900 | $45.23 |
| Q2 2022 | -403,500 | Reduce 86.85% | 61,100 | $56.06 |
| Q1 2022 | +239,300 | Add 106.21% | 464,600 | $71.11 |
| Q4 2021 | +135,200 | Add 150.06% | 225,300 | $65.26 |
| Q3 2021 | +90,100 | New Buy | 90,100 | $75.04 |
| Q4 2020 | -75,300 | Sold Out | 0 | $0.00 |
| Q3 2020 | -208,100 | Reduce 73.43% | 75,300 | $64.98 |
| Q2 2020 | +94,500 | Add 50.03% | 283,400 | $61.93 |
| Q1 2020 | +188,900 | New Buy | 188,900 | $64.03 |
| Q4 2019 | -360,532 | Sold Out | 0 | $0.00 |
| Q3 2019 | -744,968 | Reduce 67.39% | 360,532 | $63.28 |
| Q2 2019 | -1.13 M | Reduce 50.60% | 1.11 M | $63.36 |
| Q1 2019 | +80,100 | Add 3.71% | 2.24 M | $58.40 |
| Q4 2018 | +660,400 | Add 44.10% | 2.16 M | $61.70 |
| Q3 2018 | +628,300 | Add 72.28% | 1.5 M | $77.95 |
| Q2 2018 | +458,100 | Add 111.43% | 869,200 | $67.72 |
| Q1 2018 | +411,100 | New Buy | 411,100 | $57.17 |
Renaissance Technologies's Encompass Health Corporation Investment FAQs
Renaissance Technologies first purchased Encompass Health Corporation (EHC) in Q1 2018, acquiring 411,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Encompass Health Corporation (EHC) for 25 quarters since Q1 2018.
Renaissance Technologies's largest addition to Encompass Health Corporation (EHC) was in Q4 2018, adding 2,157,900 shares worth $133.14 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 68,200 shares of Encompass Health Corporation (EHC), valued at approximately $7.24 M.
As of the Q4 2025 filing, Encompass Health Corporation (EHC) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Encompass Health Corporation (EHC) was 2,238,000 shares, as reported at the end of Q1 2019.